Log on / register
Feedback | Support | My details
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.
Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F, Massard J, Bonyhay L, Tahiri M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V, LIDO Study Group , CYTOL study group
BMC Gastroenterol 2006, 6:34
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.
Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ
World J Gastroenterol 2008 Apr 28, 14:2474-86
[PubMed Central] [PubMed] [Related articles]

2.
Assessing liver fibrosis with serum marker models.
Rossi E, Adams LA, Bulsara M, Jeffrey GP
Clin Biochem Rev 2007 Feb, 28:3-10
[PubMed Central] [PubMed] [Related articles]


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.